What is Kura Oncology's quick ratio?

Kura Oncology (KURA) reported quick ratio of 6.1× in Q1 2026.

How has Kura Oncology's quick ratio changed year-over-year?

Kura Oncology's quick ratio decreased by 23.9% year-over-year, from 8.1× to 6.1×.

What is the long-term trend for Kura Oncology's quick ratio?

Over 5 years (2020 to 2025), Kura Oncology's quick ratio has grown at a -24.4% compound annual growth rate (CAGR), from 24.5× to 6.1×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

Kura Oncology KURA Quick ratio

Quick ratio at other companies

Johnson & JohnsonJNJ

0.8×-0.3×

AmgenAMGN

1×+0.1×

ExelixisEXEL

3.1×-0.2×

Syndax PharmaceuticalsSNDX

5.1×-0.7×

AbbVieABBV

0.7×0.0×

Corvus PharmaceuticalsCRVS

19.8×+14.9×

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+81.6%

Enterprise value$927.97M+90.7%

P/S13.2×+3.6×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

quick assets/total current liabilities=6.1×

Based on the most recent quarter.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's quick ratio?: Kura Oncology (KURA) reported quick ratio of 6.1× in Q1 2026.
How has Kura Oncology's quick ratio changed year-over-year?: Kura Oncology's quick ratio decreased by 23.9% year-over-year, from 8.1× to 6.1×.
What is the long-term trend for Kura Oncology's quick ratio?: Over 5 years (2020 to 2025), Kura Oncology's quick ratio has grown at a -24.4% compound annual growth rate (CAGR), from 24.5× to 6.1×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.